[Macrophage activation syndrome after treatment with infliximab for fistulated Crohn's disease] (Q81862807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

[Macrophage activation syndrome after treatment with infliximab for fistulated Crohn's disease] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

macrophage activation syndrome

1 reference

1 reference

Eric Chauveau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

François Terrier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Didier Casassus-Buihle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Xavier Moncoucy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Bernard Oddes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

French

0 references

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

0 references

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

583-584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2805%2983984-3

7 January 2021

Hemophagocytic syndromes and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2805%2983984-3

7 January 2021

Reactivation of histoplasmosis after treatment with infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2805%2983984-3

7 January 2021

Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2805%2983984-3

7 January 2021

10.1016/S0755-4982(05)83984-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962497%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference